A novel harm reduction initiative to help healthcare staff monitor and treat people who inject drugs has helped support more than 800 vulnerable people since launching.
The WAND programme, which incentivises the city’s most hard-to-reach communities to regularly engage with the health service, has helped facilitate more than 5,000 harm reduction interventions across three participating sites, with more than 1,200 WAND assessments taking place since the programme launched in September 2020.
Operating from three centres in Glasgow, the programme focusses on providing a holistic approach to addressing drug harms such as overdoses, blood borne viruses, and injecting related complications. It comprises:
- W: Wound Care
- A: Assessment of Injecting Risk
- N: Naloxone Provision
- D: Dry Blood Spot Testing
People who inject drugs can be hard to keep engaged with the health service, which is crucial in helping reduce the harms of drugs by providing advice and treatments and access to other services to help them.
WAND works by providing a £20 redeemable voucher to patients and encourages patients to return for follow up assessments every three – four months. The vouchers can then be exchanged for cash or other essentials. It’s one of a number of harm reduction programmes running across NHSGGC to help tackle the drugs crisis.
Through the interventions, staff can provide immediate care to the patients, helping avoid trips to A&E or further harm being caused further down the line. It also ensures that if a patient has a Blood Borne Virus such as HIV for example, this can be picked up at an early stage through dry blood spot testing and appropriate information and treatment can be provided to the patient.
John Campbell, Injection Equipment Provision Manager for NHSGGC, said: “WAND is by far the most successful harm reduction initiative running in Glasgow today. Individuals we look after come from the hardest to reach communities and WAND provides us with an insight and touch point with them that we would never previously have had.
“This means that through early intervention we can stop problems getting worse, which would cost more to address had they gone undiagnosed or untreated, and we can also encourage those patients to consider moving into recovery or to engage with other means of support to help them.”
As part of the 30 minute assessment, patients are also encouraged to carry naloxone with them at all times. Naloxone is a lifesaving injectable which is used to reverse overdoses. In the past year alone more than 3000 naloxone kits have been distributed, and more than 18,000 have been issued in total. Every week there are instances of naloxone being used to reverse overdoses in patients.
John Campbell added: “Naloxone is literally a life-saving device for many people. If we can ensure that our patients are trained and carry the kit at all times, it means that we’ll hopefully see far fewer deaths as a result of overdose in the future.”
The WAND initiative was recently referenced in the Scottish Drugs Deaths Taskforce report, which made the recommendation that the programme be rolled out on a larger scale due to its success in supporting and monitoring patients in the city.
21
0
20
